共 39 条
[1]
CDC, 1995, MMWR-MORBID MORTAL W, V44, P19
[2]
INCIDENCE AND NATURAL-HISTORY OF MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
[J].
AMERICAN REVIEW OF RESPIRATORY DISEASE,
1992, 146 (02)
:285-289
[3]
EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1994, 271 (09)
:698-702
[4]
PROTECTION TO MICE AFFORDED BY BCG VACCINES AGAINST AN AEROGENIC CHALLENGE BY 3 MYCOBACTERIA OF DECREASING VIRULENCE
[J].
TUBERCLE,
1985, 66 (04)
:267-276
[5]
DUBOS R, 1964, AM REV RESPIR DIS, V90, P505
[6]
SPECTRUM OF DISEASE IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE UNITED-STATES
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1992, 267 (13)
:1798-1805
[8]
Patterns of opportunistic infections in patients with HIV infection
[J].
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY,
1996, 12 (01)
:38-45
[9]
GILKS CF, 1995, J ACQ IMMUN DEF SYND, V8, P195
[10]
IS THE INCIDENCE OF AIDS-ASSOCIATED MYCOBACTERIUM-AVIUM-INTRACELLULARE DISEASE AFFECTED BY PREVIOUS EXPOSURE TO BCG, MYCOBACTERIUM-TUBERCULOSIS OR ENVIRONMENTAL MYCOBACTERIA
[J].
TUBERCLE AND LUNG DISEASE,
1994, 75 (03)
:234-236